$PURE recovery at breakout $0.80

New Post Public Reply Private Reply Replies (1) Message Board
PoemStone
$PURE recovery at breakout $0.80


Website

10-Q 12/11/14
Summery

yahoo_finance_en-US_s_f_p_191x21_finance_2x.png

Shares Outstanding: 39.79M
Float: 27.07M

% Held by Insiders: 24.89%
% Held by Institutions: 2.80%
Shares Short (as of Apr 30, 2013): 222.97K
Short Ratio (as of Apr 30, 2013)3: 2.60
Short % of Float (as of Apr 30, 2013: 2.10%
Shares Short (prior month): 226.12K


16 % Sell Composite Signal
850318709_barchart_logo1.jpg


Headlines


Saturday, December 13, 2014
10-Q for PURE Bioscience, Inc.Company Spotlight (Sat, Dec 13)

Friday, December 12, 2014
PURE Reports Fiscal First Quarter 2015 Financial ResultsZacks Small Cap Research (Fri, Dec 12)

Thursday, December 11, 2014
PURE BIOSCIENCE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhEDGAR Online (Thu, Dec 11)
PURE Bioscience Reports Fiscal First Quarter 2015 Financial ResultsMarketwired (Thu, Dec 11)

Wednesday, December 10, 2014
PURE(R) Hard Surface Disinfectant Remediates Listeria Contamination in Shuttered Food Processing FacilityMarketwired (Wed, Dec 10)

Tuesday, December 2, 2014
PURE Bioscience to Host Fiscal Q1 Investor Conference Call Thursday, December 11, 2014Marketwired (Tue, Dec 2)

Wednesday, November 12, 2014
PURE Bioscience Updates Ongoing Sales Path for EPA Approved PURE(R) Hard Surface Disinfectant With SUBWAY(R) Restaurants and OthersMarketwired (Wed, Nov 12)

Monday, November 10, 2014
PURE Withdraws Food Contact Notification for SDC Antimicrobial Use in Raw Poultry ProcessingMarketwired (Mon, Nov 10)
PURE BIOSCIENCE, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Mon, Nov 10)

Tuesday, November 4, 2014
PURE BIOSCIENCE, INC. FinancialsEDGAR Online Financials (Tue, Nov 4)

Thursday, October 30, 2014
10-K for PURE Bioscience, Inc.Company Spotlight (Thu, Oct 30)

Tuesday, October 28, 2014
PURE BIOSCIENCE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhEDGAR Online (Tue, Oct 28)
PURE Bioscience Reports Fiscal Year End 2014 Financial ResultsMarketwired (Tue, Oct 28)

Monday, October 27, 2014
PURE BIOSCIENCE, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and ExhibitEDGAR Online (Mon, Oct 27)
PURE Bioscience Names Tom Y. Lee, CPA, as Sixth Member of Its Board of DirectorsMarketwired (Mon, Oct 27)

Monday, October 20, 2014
PURE Bioscience Hosts Year-End Results Conference Call October 28, 2014 to Review Progress of SDC Antimicrobial-Based Food Safety Solutions StrategyMarketwired (Mon, Oct 20)

Friday, October 17, 2014
PURE Hard Surface Disinfectant Now Available for Use in Subway(R) Restaurants NationwideMarketwired (Fri, Oct 17)

Thursday, October 9, 2014
PURE Submits Food Contact Notification to FDA for SDC Antimicrobial Use in Produce ProcessingMarketwired (Thu, Oct 9)

Thursday, September 18, 2014
PURE: Out-Licensing Will Generate Additional Revenue for PUREZacks Small Cap Research (Thu, Sep 18)

Wednesday, September 3, 2014
PURE BIOSCIENCE, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity SecEDGAR Online (Wed, Sep 3)
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 39

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 34

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 44

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 41

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 31

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing Knee Treatment with Overture's Latest System

Updated Category News Views 312

Full Commercial Launch of the OvertureTi Knee Resurfacing System Overture Orthopaedics is making headlines as it proudly announces the full commercial launch of its advanced OvertureTi Knee Resurfacing System. This medical device targets early osteoarthritis and cartilage defects effectively, presenting a breakthrough for patients seeking alternatives to traditional joint...

Continue Reading
Elis SA: Key Insights on Recent Share Buyback Activities

Updated Category News Views 130

Elis SA's Recent Share Buyback Activities Elis SA has made a mark with its recent trading activities associated with its own shares, particularly highlighting a series of transactions carried out during a specified period. Overview of the Buyback Program As part of its strategic financial planning, Elis has engaged in a buyback program that has garnered attention. The...

Continue Reading
Kevin O'Leary's Essential Advice for Startups on Content Investment

Updated Category News Views 262

O'Leary: Tools Are Cheap, But Talent Isn't Entrepreneur and "Shark Tank" star Kevin O'Leary emphasizes a critical insight for startups: while the cost of creating digital content has drastically reduced, the true value comes from the talent that produces it. O'Leary shared his thoughts in a recent video, indicating that although the cost of technology has significantly...

Continue Reading
The St. James Reinvents Lacrosse with Spencer Ford at the Helm

Updated Category News Views 237

The St. James Strengthens Lacrosse Initiatives In an exciting development, The St. James has appointed Spencer Ford as the new Director of Lacrosse, ushering in a transformative approach to lacrosse for both boys and girls. With a vast wealth of experience spanning nearly twenty years, Ford is not only a seasoned professional player but also an accomplished coach and...

Continue Reading
Hudbay Minerals Celebrates Permit Approval for Copper World

Updated Category News Views 119

Hudbay Minerals Receives Final Permit for Copper World Project Hudbay Minerals Inc. (TSX, NYSE: HBM), a prominent player in the mining industry, has taken a significant step forward by securing the final major permit necessary for its Copper World project in Arizona. This milestone not only enhances the company’s operational capacity but also solidifies its commitment...

Continue Reading